Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: Fine mapping in search of a possible tumour suppressor gene region

Melanoma Research

Volumn 13, Issue 1, 2003, Pages 29-33

  Poetsch, Micaela ^a   Dittberner, Thomas ^a   Woenckhaus, Christian ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

1p36.3; Loss of heterozygosity; Melanoma

Indexed keywords

ALLELE; ARTICLE; CENTROMERE; CHROMOSOME 1P; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE DELETION; GENE LOCUS; GENE LOSS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; MICROSATELLITE MARKER; PRIORITY JOURNAL; SURVIVAL; TELOMERE; TUMOR SUPPRESSOR GENE;

ALLELES; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; SKIN NEOPLASMS;

EID: 0037331353     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200302000-00006     Document Type: Article

References (24)

1. Heim S, Mitelman F. Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, 2nd edition. New York: Wiley-Liss; 1995.
2. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SPL. et al. Cytogenetics of 158 patients with regional or disseminated melanoma. Cancer Genet Cytogenet 1995; 83:93-104.
3. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 1989; 86:4614-4618.
4. Böni R, Matt D, Voetmeyer A, Burg G, Zhuang Z. Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol 1998; 110:215-217.
5. Herbst RA, Mommert S, Schubach J, Podewski EK, Kapp A, Weiss J. Allelic loss at the p73 locus (1p36.33) is infrequent in malignant melanoma. Arch Dermatol Res 1999; 291:362-364.
6. Poetsch M, Woenckhaus C, Dittberner T, Pambor M, Lorenz G, Herrmann FH. Increased frequency of numerical chromosomal abnormalities and 1p36 deletions in isolated cells of paraffin sections of malignant melanoma detected by interphase cytogenetics. Cancer Genet Cytogenet 1998; 104:146-152.
7. Poetsch M, Woenckhaus C, Dittberner T, Pambor M, Lorenz G. Herrmann FH. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics. LabInvest 1998; 78:883-888.
8. Poetsch M, Dittberner T, Woenckhaus C. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet Cytogenet 2001; 125:21-26.
9. Vance JM, Matise TC, Wooster R, Schutte BC, Bruns GAP, van Roy N, et al. Report of the Third International Workshop on Human Chromosome 1 Mapping 1997. Cytogenet Cell Genet 1997; 78:153-182.
10. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996; 56:3331-3337.
11. Martinsson T, Sjoberg RM, Hallstensson K, Nordling M, Hedborg F, Kogner P. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 1997; 33:1997-2001.
12. Ejeskar K, Abel F, Sjoberg R, Backstrom J, Kogner P, Martinsson T. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-p36.2, but absence of mutations in primary tumors. Cytogenet Cell Genet 2000; 89:62-66.
13. Ejeskar K, Sjoberg RM, Abel F, Kogner P, Ambros PF, Martinsson T. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol 2001; 36:61-66.
14. Bogdan I, Xin H, Burg G, Böni R. Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res 2001; 11:349-354.
15. Poetsch M, Dittberner T, Woenckhaus C. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanoma with deletions in 1p36. Oncogene 2002; 21:3038-3042.
16. Alvarez AA, Lambers AR, Lancaster JM, Maxwell GL, Ali S, Gumbs C, et al. Allele loss on chromosome 1p36 in epithelial ovarian cancers. Gynecol Oncol 2001;:94-98.
17. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999; 18:4144-4152.
18. You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci USA 2001; 99:1455-1460.
19. Kroiss MM, Bosserhoff AK, Vogt T, Buettner R, Bogenrieder T, Landthaler M, et al. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res 1998; 8:504-509.
20. Schittek B, Sauer B, Garbe C. Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines. Int J Cancer 1999; 82:583-586.
21. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, et al. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 2001; 36:42-44.
22. Codegoni AM, Bertoni F, Patregnani C, Marinetti E, D'Incalci M, Broggini M. Allelic expression of p73 in human ovarian cancers. Ann Oncol 1999; 10:949-953.
23. Tsujimoto T, Mochizuchi S, Iwadate Y, Namba H, Nagai M, Kawamoto T, et al. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3. Anticancer Res 2000; 20:2495-2497.
24. Poetsch M, Dittberner T, Woenckhaus C. Does the PITSLRE gene complex contribute to the pathogenesis of malignant melanoma of the skin? A study with patient derived tumor samples. Cancer Genet Cytogenet 2001; 128:181-182.